Assertio Holdings, Inc. (ASRT)
23.40
-0.06
(-0.23%)
USD |
NASDAQ |
May 27, 15:48
Assertio Holdings Cash from Investing (Quarterly) : 15.11M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -11.32M |
| Corcept Therapeutics, Inc. | 4.542M |
| Merck & Co., Inc. | -10.21B |
| Lipocine, Inc. | -9.904M |
| Theravance Biopharma, Inc. | 52.59M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.563M |
| Cash from Financing (Quarterly) | -0.189M |
| Free Cash Flow | -7.081M |
| Free Cash Flow Per Share (Quarterly) | 1.331 |
| Free Cash Flow to Equity (Quarterly) | 8.503M |
| Free Cash Flow to Firm (Quarterly) | 9.340M |
| Free Cash Flow Yield | -4.59% |